期刊
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
卷 78, 期 22, 页码 2131-2143出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2021.09.864
关键词
aortic stenosis; decision making; guidelines; surgical aortic valve replacement; transcatheter aortic valve replacement
资金
- Abbott Vascular Inc
- Amgen Cardiovascular
- AstraZeneca
- Bayer AG
- Boehringer Ingelheim
- Boston Scientific
- Bristol Myers Squibb-Pfizer Alliance
- Daiichi-Sankyo Europe GmbH
- Alliance Daiichi-Sankyo Europe GmbH
- Eli Lilly and Company
- Edwards
- Gedeon Richter Plc
- ResMed
- Sanofi
- Servier
- Vifor
- Abbott
- Edwards Lifesciences
- Medtronic
- Biotronik
- GE Healthcare
- Bayer
Despite a Class I recommendation for intervention, one in five patients with severe symptomatic AS chose not to intervene, a decision particularly associated with older age and combined comorbidities. Transcatheter intervention was extensively used in octogenarians.
BACKGROUND There were gaps between guidelines and practice when surgery was the only treatment for aortic stenosis (AS). OBJECTIVES This study analyzed the decision to intervene in patients with severe AS in the EORP VHD (EURObservational Research Programme Valvular Heart Disease) II survey. METHODS Among 2,152 patients with severe AS, 1,271 patients with high-gradient AS who were symptomatic fulfilled a Class I recommendation for intervention according to the 2012 European Society of Cardiology guidelines; the primary end point was the decision for intervention. RESULTS A decision not to intervene was taken in 262 patients (20.6%). In multivariate analysis, the decision not to intervene was associated with older age (odds ratio [OR]: 1.34 per 10-year increase; 95% CI: 1.11 to 1.61; P = 0.002), New York Heart Association functional classes I and II versus III (OR: 1.63; 95% CI: 1.16 to 2.30; P = 0.005), higher age adjusted Charlson comorbidity index (OR: 1.09 per 1-point increase; 95% CI: 1.01 to 1.17; P = 0.03), and a lower transaortic mean gradient (OR: 0.81 per 10-mm Hg decrease; 95% CI: 0.71 to 0.92; P < 0.001). During the study period, 346 patients (40.2%, median age 84 years, median EuroSCORE II [European System for Cardiac Operative Risk Evaluation II] 3.1%) underwent transcatheter intervention and 515 (59.8%, median age 69 years, median EuroSCORE II 1.5%) underwent surgery. A decision not to intervene versus intervention was associated with lower 6-month survival (87.4%; 95% CI: 82.0 to 91.3 vs 94.6%; 95% CI: 92.8 to 95.9; P < 0.001). CONCLUSIONS A decision not to intervene was taken in 1 in 5 patients with severe symptomatic AS despite a Class I recommendation for intervention and the decision was particularly associated with older age and combined comorbidities. Transcatheter intervention was extensively used in octogenarians. (J Am Coll Cardiol 2021;78:2131-2143) (c) 2021 by the American College of Cardiology Foundation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据